![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3989|18|1|15-22
ISSN: 1871-5265
Source: Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.18, Iss.1, 2018-03, pp. : 15-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HAART accounts for large increase in HIV/AIDS costs in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 429, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HAART accounts for large increase in HIV/AIDS costs in Canada
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etravirine for the treatment of HIV/AIDS
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nanomedicines as Therapeutics in HIV-AIDS
Pharmaceutical Nanotechnology, Vol. 4, Iss. 4, 2016-12 ,pp. :